The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Sep. 13, 2024
Applicant:
Astrazeneca Ab, Södertälje, SE;
Inventors:
Daniel Tor Pettersen, Södertälje, SE;
Stéphanie Marcelle Gueret, Södertälje, SE;
Nidhal Selmi, Södertälje, SE;
Erik Lars Malmerberg, Södertälje, SE;
Tord Bertil Inghardt, Södertälje, SE;
Jan Åke Lindberg, Södertälje, SE;
Jens Peter Brandt, Södertälje, SE;
Jon Paul Janet, Södertälje, SE;
Björn Erik Anton Holm, Södertälje, SE;
Assignee:
ASTRAZENECA AB, Sodertalje, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/06 (2005.12); C07D 271/06 (2005.12); C07D 409/06 (2005.12); C07D 413/04 (2005.12); C07D 413/12 (2005.12); C07D 413/14 (2005.12); C07D 471/04 (2005.12); C07D 487/04 (2005.12); C07D 498/10 (2005.12);
U.S. Cl.
CPC ...
C07D 413/06 (2012.12); C07D 271/06 (2012.12); C07D 409/06 (2012.12); C07D 413/04 (2012.12); C07D 413/12 (2012.12); C07D 413/14 (2012.12); C07D 471/04 (2012.12); C07D 487/04 (2012.12); C07D 498/10 (2012.12);
Abstract
The specification relates to compounds of Formula (I): and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of diseases such as liver disease.